After decades of increases, diabetes-related health care costs have plateaued, according to a new Trends in Spend report from Nomi Health.

A new study has suggested the benefits of GLP-1 agonists could extend to a reduction in the risk of a slew of cancers associated with being overweight. The observational study of more than 170,000 ...

When it comes to weight loss, we’re all after a magic bullet, a simple, stress-free way of shedding the excess pounds. And so for millions around the world, the arrival of the so-called GLP-1 ...

Get the latest news and real-time alerts from Novo Nordisk A/S (NVO) stock at Seeking Alpha.